Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Revolve Group
RVLV
$1.68B
| $1.1M | ﹤0.01% |
67,269
+3,472
| +5% | +$64.7K |
|
3202
Pacira BioSciences
PCRX
$917M
| $1.1M | ﹤0.01% |
27,536
+15,013
| +120% | +$621K |
|
3203
ProShares UltraPro Short 20+ Year Treasury
TTT
$18.6M
| $1.1M | ﹤0.01% |
+16,771
| New | +$1.09M |
|
3204
Peabody Energy
BTU
$3.11B
| $1.1M | ﹤0.01% |
50,839
+9,271
| +22% | +$205K |
|
3205
iShares MSCI Netherlands ETF
EWN
$738M
| $1.1M | ﹤0.01% |
25,415
-51,868
| -67% | -$2.19M |
|
|
SPTN
3206
DELISTED
SpartanNash
SPTN
| $1.1M | ﹤0.01% |
48,893
+2,732
| +6% | +$64K |
|
|
SWTX
3207
DELISTED
SpringWorks Therapeutics
SWTX
| $1.1M | ﹤0.01% |
41,987
+14,310
| +52% | +$376K |
|
3208
Golar LNG
GLNG
$5.36B
| $1.1M | ﹤0.01% |
54,587
-51,068
| -48% | -$1.1M |
|
3209
Mueller Water Products
MWA
$3.99B
| $1.1M | ﹤0.01% |
67,741
-35,313
| -34% | -$502K |
|
3210
Under Armour
UAA
$2.3B
| $1.1M | ﹤0.01% |
152,133
-21,274
| -12% | -$171K |
|
3211
EA Bridgeway Blue Chip ETF
BBLU
$461M
| $1.1M | ﹤0.01% |
111,612
+21,227
| +23% | +$195K |
|
3212
Custom Truck One Source
CTOS
$2.4B
| $1.1M | ﹤0.01% |
162,879
+10,406
| +7% | +$68.5K |
|
3213
FT Vest Growth-100 Buffer ETF March
QMAR
$583M
| $1.1M | ﹤0.01% |
+45,832
| New | +$1.05M |
|
3214
TIM SA
TIMB
$8.29B
| $1.1M | ﹤0.01% |
71,779
+2,365
| +3% | +$33.4K |
|
3215
Franklin Investment Grade Corporate ETF
FLCO
$556M
| $1.1M | ﹤0.01% |
51,721
+22,097
| +75% | +$470K |
|
3216
CALL
Kinder Morgan
KMI
$73.1B
| $1.1M | ﹤0.01% |
63,700
-127,400
| -67% | -$2.16M |
|
|
EDD
3217
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$372M
| $1.1M | ﹤0.01% |
233,649
+16,687
| +8% | +$78.7K |
|
3218
Crescent Capital BDC
CCAP
$411M
| $1.09M | ﹤0.01% |
72,311
+8,989
| +14% | +$126K |
|
3219
Sixth Street Specialty
TSLX
$1.78B
| $1.09M | ﹤0.01% |
58,536
-7,422
| -11% | -$135K |
|
3220
Asana
ASAN
$2.11B
| $1.09M | ﹤0.01% |
49,641
+31,006
| +166% | +$622K |
|
3221
Invesco BulletShares 2028 High Yield Corporate Bond ETF
BSJS
$744M
| $1.09M | ﹤0.01% |
52,079
+50,066
| +2,487% | +$1.05M |
|
3222
WisdomTree International Equity Fund
DWM
$694M
| $1.09M | ﹤0.01% |
21,845
-7,408
| -25% | -$374K |
|
3223
Alpha Architect US Quantitative Momentum ETF
QMOM
$450M
| $1.09M | ﹤0.01% |
23,498
+12,878
| +121% | +$573K |
|
3224
Fresenius Medical Care
FMS
$12.7B
| $1.09M | ﹤0.01% |
45,505
-3,583
| -7% | -$82.2K |
|
3225
Flywire
FLYW
$2.29B
| $1.09M | ﹤0.01% |
35,047
-7,579
| -18% | -$227K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 675 new, 3,796 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 675 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.